Qube Research & Technologies LTD Editas Medicine, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.03 - $11.07 $4.65 Million - $7.33 Million	661,810 Added 172.6%	1,045,255 $7.76 Million
Q4 2023 Feb 13, 2024	BUY	$6.25 - $11.11 $2.4 Million - $4.26 Million	383,445 New	383,445 $3.88 Million
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $535,569 - $965,877	84,209 Added 50.49%	250,991 $2.07 Million
Q1 2023 May 15, 2023	BUY	$7.03 - $11.53 $939,946 - $1.54 Million	133,705 Added 404.22%	166,782 $1.21 Million
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $955,568 - $1.52 Million	-114,852 Reduced 77.64%	33,077 $293,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $1.8 Million - $2.87 Million	147,929 New	147,929 $1.81 Million
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $186,892 - $399,415	-18,708 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$14.08 - $27.63 $114,090 - $223,885	-8,103 Reduced 30.22%	18,708 $356,000
Q4 2021 Feb 01, 2022	BUY	$26.55 - $40.57 $145,228 - $221,917	5,470 Added 25.63%	26,811 $712,000
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $838,061 - $1.56 Million	21,341 New	21,341 $877,000
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $484,556 - $877,127	-15,486 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $614,949 - $1.4 Million	15,486 New	15,486 $650,000
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $463,113 - $1.44 Million	-17,108 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $480,050 - $635,733	17,108 New	17,108 $480,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $535,486 - $1.18 Million	-35,987 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$19.49 - $32.63 $701,386 - $1.17 Million	35,987 New	35,987 $1.07 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account